Louisa Jones
Nurse Practitioner · Clarksville, TNNPI 1568997344
Payments from drug & device makers
Across 253 payments — averaging $21.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$1K
- Regeneron Healthcare Solutions, Inc.$498
- Grifols USA, LLC$383
- Sanofi$361
- Mylan Specialty L.p.$263
- plus $2K from 27 others
What the payments were for
- Food & beverage$5,28496%
- Education$1954%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 47 | $1,139 |
| GSK | 52 | $1,072 |
| Regeneron Healthcare Solutions, Inc. | 19 | $498 |
| Grifols USA, LLC | 19 | $383 |
| Sanofi | 13 | $361 |
| Mylan Specialty L.p. | 16 | $263 |
| Viatris Specialty LLC | 13 | $251 |
| Verona Pharma, Inc. | 11 | $234 |
| Insmed, Inc. | 16 | $233 |
| Actelion Pharmaceuticals US, Inc. | 6 | $183 |
| Electromed, Inc. | 9 | $133 |
| Jazz Pharmaceuticals Inc. | 3 | $83 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $72 |
| Harmony Biosciences LLC | 3 | $66 |
| Nevro Corp. | 2 | $49 |
| AbbVie | 1 | $44 |
| Boehringer Ingelheim | 2 | $37 |
| Pfizer | 2 | $36 |
| Pulmonx Corporation | 1 | $35 |
| Bayer | 1 | $30 |
| La Jolla Pharmaceutical Company | 1 | $27 |
| ZOLL Respicardia, Inc. | 2 | $26 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Amgen | 1 | $25 |
| 3b Medical, Inc. | 1 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Novo Nordisk | 1 | $22 |
| United Therapeutics Corporation | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Breas Medical, Inc. | 1 | $16 |
| Inogen, Inc. | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,478 in reported general payments places this provider in the 90th percentile of 2,662 nurse practitioner providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 176 | $185,112 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 78 | $65,701 |
| Spiriva RespimatTiotropium Bromide | 33 | $27,409 |
| Advair HfaFluticasone Propion/Salmeterol | 16 | $10,397 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 13 | $10,093 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $9,524 |
| SymbicortBudesonide/Formoterol Fumarate | 17 | $7,628 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 184 | $5,672 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 31 | $5,319 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 13 | $3,339 |
| Arnuity ElliptaFluticasone Furoate | 12 | $2,376 |
| Montelukast Sodium | 169 | $1,885 |
| Ventolin HfaAlbuterol Sulfate | 23 | $1,648 |
| Fluticasone Propionate | 85 | $1,541 |
| Azelastine Hcl | 19 | $588 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $1,072 | $197,012207 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,139 | $73,32995 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $37 | $37,50246 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,662 nurse practitioner providers in Tennessee.
Other nurse practitioner in Clarksville
- Amy HatcherMurfreesboro$1.1M
- Karen RodenKnoxville$265K
- Susan UtleyNashville$194K
- Whitney EricksonMemphis$159K
- Erica HembreeKnoxville$125K
- Brooke FaughtNashville$89K
- Lauren WelchNashville$71K
- Cara StoutKingsport$71K
- S Marie HamiltonOoltewah$64K
- Cynthia WilsonChattanooga$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.